Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33


Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study.

Siljan WW, Holter JC, Michelsen AE, Nymo SH, Lauritzen T, Oppen K, Husebye E, Ueland T, Mollnes TE, Aukrust P, Heggelund L.

ERJ Open Res. 2019 Mar 11;5(1). pii: 00014-2019. doi: 10.1183/23120541.00014-2019. eCollection 2019 Feb.


Low Levels of Immunoglobulins and Mannose-Binding Lectin Are Not Associated With Etiology, Severity, or Outcome in Community-Acquired Pneumonia.

Siljan WW, Holter JC, Nymo SH, Husebye E, Ueland T, Skattum L, Bosnes V, Garred P, Frøland SS, Mollnes TE, Aukrust P, Heggelund L.

Open Forum Infect Dis. 2018 Jan 5;5(2):ofy002. doi: 10.1093/ofid/ofy002. eCollection 2018 Feb.


Cytokine responses, microbial aetiology and short-term outcome in community-acquired pneumonia.

Siljan WW, Holter JC, Nymo SH, Husebye E, Ueland T, Aukrust P, Mollnes TE, Heggelund L.

Eur J Clin Invest. 2018 Jan;48(1). doi: 10.1111/eci.12865. Epub 2017 Dec 7.


Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study.

Dalgard O, Weiland O, Noraberg G, Karlsen L, Heggelund L, Färkkilâ M, Balslev U, Belard E, Øvrehus A, Skalshøi Kjær M, Krarup H, Thorup Røge B, Hallager S, Madsen LG, Lund Laursen A, Lagging M, Weis N.

PLoS One. 2017 Jul 13;12(7):e0179764. doi: 10.1371/journal.pone.0179764. eCollection 2017.


[Water lily sign].

Svenne IS, Tangerud Å, Heggelund L.

Tidsskr Nor Laegeforen. 2017 Mar 21;137(6):455. doi: 10.4045/tidsskr.16.0877. eCollection 2017 Mar. Norwegian. No abstract available.


Circulating cell-free DNA is elevated in community-acquired bacterial pneumonia and predicts short-term outcome.

Siljan WW, Holter JC, Nymo SH, Schjalm C, Müller F, Jenum PA, Husebye E, Ueland T, Aukrust P, Mollnes TE, Heggelund L.

J Infect. 2016 Oct;73(4):383-6. doi: 10.1016/j.jinf.2016.07.011. Epub 2016 Jul 21. No abstract available.


Vitamin D Status and Long-Term Mortality in Community-Acquired Pneumonia: Secondary Data Analysis from a Prospective Cohort.

Holter JC, Ueland T, Norseth J, Brunborg C, Frøland SS, Husebye E, Aukrust P, Heggelund L.

PLoS One. 2016 Jul 1;11(7):e0158536. doi: 10.1371/journal.pone.0158536. eCollection 2016.


Semi-quantitative analysis of solid waste flows from nano-enabled consumer products in Europe, Denmark and the United Kingdom - Abundance, distribution and management.

Heggelund L, Hansen SF, Astrup TF, Boldrin A.

Waste Manag. 2016 Oct;56:584-92. doi: 10.1016/j.wasman.2016.05.030. Epub 2016 Jun 13.


Meeting the Needs for Released Nanomaterials Required for Further Testing-The SUN Approach.

Nowack B, Boldrin A, Caballero A, Hansen SF, Gottschalk F, Heggelund L, Hennig M, Mackevica A, Maes H, Navratilova J, Neubauer N, Peters R, Rose J, Schäffer A, Scifo L, van Leeuwen Sv, von der Kammer F, Wohlleben W, Wyrwoll A, Hristozov D.

Environ Sci Technol. 2016 Mar 15;50(6):2747-53. doi: 10.1021/acs.est.5b04472. Epub 2016 Mar 4.


Risk Factors for Long-Term Mortality after Hospitalization for Community-Acquired Pneumonia: A 5-Year Prospective Follow-Up Study.

Holter JC, Ueland T, Jenum PA, Müller F, Brunborg C, Frøland SS, Aukrust P, Husebye E, Heggelund L.

PLoS One. 2016 Feb 5;11(2):e0148741. doi: 10.1371/journal.pone.0148741. eCollection 2016.


Hepatitis C reinfection after sustained virological response.

Midgard H, Bjøro B, Mæland A, Konopski Z, Kileng H, Damås JK, Paulsen J, Heggelund L, Sandvei PK, Ringstad JO, Karlsen LN, Stene-Johansen K, Pettersson JH, Dorenberg DH, Dalgard O.

J Hepatol. 2016 May;64(5):1020-1026. doi: 10.1016/j.jhep.2016.01.001. Epub 2016 Jan 11.


Corynebacterium pseudotuberculosis Pneumonia in a Veterinary Student Infected During Laboratory Work.

Heggelund L, Gaustad P, Håvelsrud OE, Blom J, Borgen L, Sundset A, Sørum H, Frøland SS.

Open Forum Infect Dis. 2015 Apr 15;2(2):ofv053. doi: 10.1093/ofid/ofv053. eCollection 2015 Apr.


Soil pH effects on the interactions between dissolved zinc, non-nano- and nano-ZnO with soil bacterial communities.

Read DS, Matzke M, Gweon HS, Newbold LK, Heggelund L, Ortiz MD, Lahive E, Spurgeon D, Svendsen C.

Environ Sci Pollut Res Int. 2016 Mar;23(5):4120-8. doi: 10.1007/s11356-015-4538-z. Epub 2015 Apr 24.


Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway.

Holter JC, Müller F, Bjørang O, Samdal HH, Marthinsen JB, Jenum PA, Ueland T, Frøland SS, Aukrust P, Husebye E, Heggelund L.

BMC Infect Dis. 2015 Feb 15;15:64. doi: 10.1186/s12879-015-0803-5.


Low prevalence of positive interferon-gamma tests in HIV-positive long-term immigrants in Norway.

Pullar ND, Steinum H, Tonby K, Heggelund L, Leiva RA, Ofstad R, Bruun JN, Dyrhol-Riise AM.

Int J Tuberc Lung Dis. 2014 Feb;18(2):180-7. doi: 10.5588/ijtld.13.0276.


Soil pH effects on the comparative toxicity of dissolved zinc, non-nano and nano ZnO to the earthworm Eisenia fetida.

Heggelund LR, Diez-Ortiz M, Lofts S, Lahive E, Jurkschat K, Wojnarowicz J, Cedergreen N, Spurgeon D, Svendsen C.

Nanotoxicology. 2014 Aug;8(5):559-72. doi: 10.3109/17435390.2013.809808. Epub 2013 Jun 20.


Identification of NDM-1-producing Enterobacteriaceae in Norway.

Samuelsen Ø, Thilesen CM, Heggelund L, Vada AN, Kümmel A, Sundsfjord A.

J Antimicrob Chemother. 2011 Mar;66(3):670-2. doi: 10.1093/jac/dkq483. Epub 2010 Dec 16. No abstract available.


[Dramatic case report caused by a rare bacteria].

Dale E, Heggelund L, Leegard TM, Samdal HH, Edvardsen T, Gjertsen E.

Tidsskr Nor Laegeforen. 2010 Jan 28;130(2):149-51. doi: 10.4045/tidsskr.08.0715. Norwegian. No abstract available.


CXCL16 in HIV infection - a link between inflammation and viral replication.

Landrø L, Damås JK, Halvorsen B, Fevang B, Ueland T, Otterdal K, Heggelund L, Frøland SS, Aukrust P.

Eur J Clin Invest. 2009 Nov;39(11):1017-24. doi: 10.1111/j.1365-2362.2009.02207.x. Epub 2009 Aug 11.


Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication.

Damås JK, Landrø L, Fevang B, Heggelund L, Tjønnfjord GE, Fløisand Y, Halvorsen B, Frøland SS, Aukrust P.

Clin Exp Immunol. 2009 Sep;157(3):400-7. doi: 10.1111/j.1365-2249.2009.03976.x.


Enhanced levels of the CCR7 ligands CCL19 and CCL21 in HIV infection: correlation with viral load, disease progression and response to highly active antiretroviral therapy.

Damås JK, Landrø L, Fevang B, Heggelund L, Frøland SS, Aukrust P.

AIDS. 2009 Jan 2;23(1):135-8. doi: 10.1097/QAD.0b013e32831cf595.


Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy.

Landrø L, Damås JK, Flo TH, Heggelund L, Ueland T, Tjønnfjord GE, Espevik T, Aukrust P, Frøland SS.

Clin Exp Immunol. 2008 Apr;152(1):57-63. doi: 10.1111/j.1365-2249.2008.03592.x. Epub 2008 Jan 28.


Severe case of invasive community-acquired methicillin-resistant Staphylococcus aureus infection in Norway.

Heggelund L, Holm Samdal H, Eggum R, Jacobsen T, Bruun T, Elstrøm P.

Euro Surveill. 2007 Nov 8;12(11):E071108.3. No abstract available.


Modulatory effect of mannose-binding lectin on cytokine responses: possible roles in HIV infection.

Heggelund L, Mollnes TE, Espevik T, Müller F, Kristiansen KI, Aukrust P, Frøland SS.

Eur J Clin Invest. 2005 Dec;35(12):765-70.


Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis.

Fevang B, Mollnes TE, Holm AM, Ueland T, Heggelund L, Damås JK, Aukrust P, Frøland SS.

Clin Exp Immunol. 2005 Dec;142(3):576-84.


Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTES.

Holven KB, Damås JK, Yndestad A, Waehre T, Ueland T, Halvorsen B, Heggelund L, Sandberg WJ, Semb AG, Frøland SS, Ose L, Nenseter MS, Aukrust P.

Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):200-5. Epub 2005 Oct 27.


Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation.

Fiane AE, Ueland T, Simonsen S, Scott H, Endresen K, Gullestad L, Geiran OR, Haraldsen G, Heggelund L, Andreassen AK, Wergeland R, Frøland S, Aukrust P, Mollnes TE.

Eur Heart J. 2005 Aug;26(16):1660-5. Epub 2005 Apr 8.


Soluble toll-like receptor 2 in HIV infection: association with disease progression.

Heggelund L, Flo T, Berg K, Lien E, Mollnes TE, Ueland T, Aukrust P, Espevik T, Frøland SS.

AIDS. 2004 Dec 3;18(18):2437-9. No abstract available.


Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences.

Heggelund L, Damås JK, Yndestad A, Holm AM, Mūller F, Lien E, Espevik T, Aukrust P, Frøland SS.

Clin Exp Immunol. 2004 Oct;138(1):116-21. Erratum in: Clin Exp Immunol. 2004 Dec;138(3):554.


Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication.

Heggelund L, Müller F, Lien E, Yndestad A, Ueland T, Kristiansen KI, Espevik T, Aukrust P, Frøland SS.

Clin Infect Dis. 2004 Jul 15;39(2):264-9. Epub 2004 Jun 18.


Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair.

Fiane AE, Videm V, Lingaas PS, Heggelund L, Nielsen EW, Geiran OR, Fung M, Mollnes TE.

Circulation. 2003 Aug 19;108(7):849-56. Epub 2003 Aug 4.


Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patients.

Stylianou E, Bjerkeli V, Yndestad A, Heggelund L, Waehre T, Damås JK, Aukrust P, Frøland SS.

Clin Exp Immunol. 2003 Jun;132(3):462-6.


Mannose-binding lectin in HIV infection: relation to disease progression and highly active antiretroviral therapy.

Heggelund L, Mollnes TE, Ueland T, Christophersen B, Aukrust P, Frøland SS.

J Acquir Immune Defic Syndr. 2003 Apr 1;32(4):354-61.


Supplemental Content

Loading ...
Support Center